Skip to content

Form 4 filed by Collins Helen Louise

Collins Helen Louise filed this Form 4 on ELVN (Enliven Therapeutics, Inc.) with 3 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-21 21:51:36 UTC.

Accession
0001701247-26-000014
Filed
2026-10-21
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: ELVN · Enliven Therapeutics, Inc. (CIK 1672619)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-10-19M exercised+5,000$2.4830,000D
Common Stock 2026-10-19S sold-5,000$38.468425,000D
Stock Option (right to buy) derivative2026-10-19M exercised-5,000$0101,268D